Immune cells from Patients' own tumors tested in kids with advanced cancer
NCT ID NCT06566092
First seen Apr 25, 2026 · Last updated Jun 16, 2026 · Updated 9 times
Summary
This early-stage study tests whether a treatment made from a patient's own tumor-fighting immune cells (TIL) is safe for children, teenagers, and young adults with solid tumors that have come back or stopped responding to standard care. About 40 participants will receive the TIL infusion and be monitored for side effects and tumor shrinkage. The goal is to see if this approach can control the disease, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Colorado
Aurora, Colorado, 80045, United States
-
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14203, United States
-
Rutgers Cancer Institute
New Brunswick, New Jersey, 08901, United States
Conditions
Explore the condition pages connected to this study.